Search Within

Hematologic Malignancies, Division of

Formats
  1. Meeting Abstract (6372)
  2. Journal Article (5780)
  3. Review (420)
  4. Editorial (194)
  5. Book Section (188)
  6. Research Letter (179)
  7. Guidelines (88)
  8. Conference Paper (65)
  9. Correspondence (62)
  10. Miscellaneous (18)
  11. Book Whole (9)
Groups
  1. Department of Medicine (13274)
  2. Center for Hematologic Malignancies (10609)
  3. GSK Faculty (4481)
  4. Adult Leukemia (3672)
  5. Bone Marrow Transplant (2848)
  6. Lymphoma (2704)

More Groups

People
  1. Sergio Giralt (1069)
  2. Miguel-Angel Perales (943)
  3. Ross Levine (787)
  4. Andrew Zelenetz (784)
  5. Steven Horwitz (669)
  6. Martin Tallman (655)

More People

Years
  1. 2025 (336)
  2. 2024 (823)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3529)
  2. Journal of Clinical Oncology (1233)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (329)
  5. Haematologica (291)
  6. Bone Marrow Transplantation (239)

More Publications

Publishers
  1. American Society of Hematology (3806)
  2. Elsevier Inc. (1529)
  3. American Society of Clinical Oncology (1288)
  4. Nature Publishing Group (1009)
  5. American Association for Cancer Research (641)
  6. Wiley Blackwell (433)

More Publishers

Results (13375)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Improved molecular design and immunization route of CD20 peptides induce antibody against human CD20 protein
    Meeting Abstract

    Dao, T.; Antczak, C.; Boutsalis, G.; Kou, C.; Jaggi, J.; Kappel, B.; Pinilla-Ibarz, J.; Scheinberg, D. A.
    Blood (2003)

    Fulltext@MSK | Save
  • Serious complications following unrelated donor marrow collection: Experiences of the National Marrow Donor Program (R)
    Meeting Abstract

    Confer, D. L.; Leitman, S. F.; Papadopoulos, E. B.; Price, T. H.; Stroncek, D. F.; Robinett, P.; Braem, B.
    Blood (2003)

    Fulltext@MSK | Save
  • Doxorubicin and dexamethasone (AD) followed by thalidomide and dexamethasone (TD) as initial therapy for symptomatic patients with multiple myeloma
    Meeting Abstract

    Comenzo, R. L.; Hassoun, H.; Reich, L.; Klimek, V.; Kewalramani, T.; Dhodapkar, M.; Drake, L.; Hedvat, C.; Teruya-Feldstein, J.; Fleisher, M.; more...
    Blood (2003)

    Fulltext@MSK | Save
  • The BEXXAR (R) therapeutic regimen (Tositumomab and Iodine I 131 tositumomab) produced durable complete remissions in heavily pretreated patients with non-Hodgkin's lymphoma (NHL), rituximab-relapsed/refractory disease, and rituximab-naive disease
    Meeting Abstract

    Coleman, M.; Kaminski, M. S.; Knox, S. J.; Zelenetz, A. D.; Vose, J. M.
    Blood (2003)

    Fulltext@MSK | Save
  • Systemic AL amyloidosis due to non-Hodgkin's lymphoma: An unusual clinicopathologic association
    Meeting Abstract

    Cohen, A. D.; Zhou, P.; Xiao, Q. X.; Fleisher, M.; Kalakonda, N.; Akhurst, T.; Chitale, D. A.; Moskowitz, C.; Dhodapkar, M. V.; Teruya-Feldstein, J.; more...
    Blood (2003)

    Fulltext@MSK | Save
  • Development of a curative treatment program for chronic myelogenous leukemia (CML)
    Meeting Abstract

    Clarkson, B.; Veach, D.; Bornmann, W. G.
    Abstracts of Papers of the American Chemical Society (2003)

    Fulltext@MSK | Save
  • Optimization of human CD34 positive cell transduction using PG13 retroviral vector supernatant produced under serum free condition
    Meeting Abstract

    Budak-Alpdogan, T.; Przybylowski, M. D.; Fan, Y.; Sadelain, M.; Bertino, J. R.; Riviere, I.
    Blood (2003)

    Fulltext@MSK | Save
  • Expression and modulation of the inhibitory Fc gamma receptor, Fc gamma RIIb (CD32b), on human dendritic cells (DCs)
    Meeting Abstract

    Boruchov, A. M.; Young, J. W.
    Blood (2003)

    Fulltext@MSK | Save
  • Design, synthesis and SAR of actinonin analogs
    Meeting Abstract

    Borella, C. P.; Bornmann, W. G.; Scheinberg, D. A.; Sirotnak, F.; Lee, M.
    Abstracts of Papers of the American Chemical Society (2003)

    Fulltext@MSK | Save
  • Assessment of treatment-related myelodysplastic syndromes (tMDS) and acute myeloid leukemia (tAML) in patients with low-grade non-Hodgkin's lymphoma (LG-NHL) treated with tositumomab and iodine-131 tositumomab (the BEXXAR (R) therapeutic regimen)
    Meeting Abstract

    Bennett, J. M.; Kaminski, M. S.; Knox, S. J.; Zelenetz, A. D.; Leonard, J. P.; Vose, J. M.; Horning, S.
    Blood (2003)

    Fulltext@MSK | Save